Literature DB >> 30554221

The Short- and Long-Term Outcomes in Elderly Patients with Hepatocellular Carcinoma after Curative Surgery: A Case-Controlled Study with Propensity Score Matching.

Yukiyasu Okamura1, Teiichi Sugiura2, Takaaki Ito2, Yusuke Yamamoto2, Ryo Ashida2, Katsuhiko Uesaka2.   

Abstract

BACKGROUND: With aging populations increasing in developed countries, the prevalence of elderly patients with hepatocellular carcinoma (HCC) is expected to rise. The aim of this study was to determine the short- and long-term outcomes of HCC surgery in elderly patients (≥75 years) using propensity score matching.
METHODS: The study group included 421 patients who underwent hepatectomy as their initial treatment with curative intent. The patients were divided into elderly (n = 111) and non-elderly (n = 310) groups. We applied propensity score matching - taking into consideration patient background, blood examination, and tumor factors - to minimize the effect of potential confounders. We then compared the results before and after the propensity matching.
RESULTS: Before propensity matching, the elderly group included significantly more patients with a high American Society of Anesthesiologists physical status (p < 0.001). In addition, they were taking antihypertensive drugs or an anticoagulant (both p < 0.001). The severe postoperative complications and the overall survival rates for these elderly patients were significantly poorer than for the non-elderly patients (p = 0.015 and p = 0.030, respectively). We then chose 70 patients from each group for whom the preoperative confounding factors were balanced and compared the two groups. The factors identified before matching (severe complications and overall survival rates) were no longer relevant, i.e. there were no significant differences between the two groups.
CONCLUSION: Hepatectomy for HCC in elderly patients is justified.
© 2018 S. Karger AG, Basel.

Entities:  

Keywords:  Curative hepatectomy; Elderly patients; Hepatocellular carcinoma; Long-term outcomes; Propensity score matching

Mesh:

Year:  2018        PMID: 30554221     DOI: 10.1159/000494733

Source DB:  PubMed          Journal:  Eur Surg Res        ISSN: 0014-312X            Impact factor:   1.745


  6 in total

Review 1.  A Review of Hepatocellular Carcinoma in Elderly Patients Focused on Management and Outcomes.

Authors:  Eunae Cho; Hyun A Cho; Chung Hwan Jun; Hee Joon Kim; Sung Bum Cho; Sung Kyu Choi
Journal:  In Vivo       Date:  2019 Sep-Oct       Impact factor: 2.155

2.  Liver resection for octogenarians in a French center: prolonged hepatic pedicle occlusion and male sex increase major complications.

Authors:  Kenji Yoshino; Yanis Hamzaoui; Tomoaki Yoh; Fadhel Samir Ftériche; Béatrice Aussilhou; Aurélie Beaufrère; Jacques Belghiti; Olivier Soubrane; François Cauchy; Safi Dokmak
Journal:  Langenbecks Arch Surg       Date:  2021-05-31       Impact factor: 3.445

3.  New landscapes and horizons in hepatocellular carcinoma therapy.

Authors:  Melchiorre Cervello; Maria R Emma; Giuseppa Augello; Antonella Cusimano; Lydia Giannitrapani; Maurizio Soresi; Shaw M Akula; Stephen L Abrams; Linda S Steelman; Alessandro Gulino; Beatrice Belmonte; Giuseppe Montalto; James A McCubrey
Journal:  Aging (Albany NY)       Date:  2020-02-04       Impact factor: 5.682

4.  Short-term outcomes of laparoscopic versus open liver resection for hepatocellular carcinoma in older patients: a propensity score matching analysis.

Authors:  Kazuteru Monden; Hiroshi Sadamori; Masayoshi Hioki; Satoshi Ohno; Norihisa Takakura
Journal:  BMC Surg       Date:  2022-02-23       Impact factor: 2.102

5.  Editorial on "Laparoscopic versus open liver resection for hepatocellular carcinoma in elderly patients: a propensity score matching analysis".

Authors:  Jean Gugenheim; Tarek Debs
Journal:  Hepatobiliary Surg Nutr       Date:  2022-08       Impact factor: 8.265

Review 6.  How to Treat Hepatocellular Carcinoma in Elderly Patients.

Authors:  Piera Federico; Emilio Francesco Giunta; Annalisa Pappalardo; Andrea Tufo; Gianpaolo Marte; Laura Attademo; Antonietta Fabbrocini; Angelica Petrillo; Bruno Daniele
Journal:  Pharmaceuticals (Basel)       Date:  2021-03-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.